美国政府向 Moderna 提供 1.76 亿美元资助，用于加速禽流感 (H5N1) mRNA 疫苗研发。 U.S. government funds Moderna $176m for accelerating bird flu (H5N1) mRNA vaccine development.

美国政府向 Moderna 提供 1.76 亿美元，以加速开发针对禽流感 (H5N1) 的 mRNA 流感疫苗。 The U.S. government is providing Moderna $176 million to accelerate the development of an mRNA pandemic flu vaccine targeting bird flu (H5N1). 该笔资金旨在推动研究并可能为未来的流感大流行提供解决方案。 The funding aims to advance research and potentially offer a solution to future influenza pandemics. Moderna 的 mRNA 候选疫苗目前正处于早期测试阶段，其使用的技术与快速开发和推出 COVID-19 疫苗的技术相同。 Moderna's mRNA vaccine candidate is currently in early-stage testing, using the same technology that enabled rapid development and rollout of COVID-19 vaccines.